Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mount Sinai Medical Center & Miami Heart Institute

https://www.msmc.com/

Latest From Mount Sinai Medical Center & Miami Heart Institute

VasoGenix Pharmaceuticals Inc.

VasoGenix Pharmaceuticals Inc. is developing a naturally occurring cardioprotectant as a front-line treatment for myocardial infarction. Its calcitonin gene related peptide drug is designed not only to restore blood flow, but also to also actively protect cardiac tissue.

BioPharmaceutical
See All

Company Information

  • Industry
  • Academic and Research Institutions
UsernamePublicRestriction

Register